Clinical Trial Update: Cross-linked CMC and Silk Proteins in Corneal Re-epithelization

View source ↗

Summary

A clinical trial evaluates a cross-linked carboxymethylcellulose and silk protein formulation for corneal epithelial wound healing; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Epithelial Wound Healing

Drugs mentioned

• Cross-linked carboxymethylcellulose and silk protein formulation for corneal re-epithelization

Snippet

Sponsor: D&V FARMA srl | Conditions: Corneal Epithelial Wound Healing | Status: COMPLETED